These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 28212898

  • 1. Low serum iron is associated with high serum intact FGF23 in elderly men: The Swedish MrOS study.
    Lewerin C, Ljunggren Ö, Nilsson-Ehle H, Karlsson MK, Herlitz H, Lorentzon M, Ohlsson C, Mellström D.
    Bone; 2017 May; 98():1-8. PubMed ID: 28212898
    [Abstract] [Full Text] [Related]

  • 2. Plasma fibroblast growth factor 23 concentration and iron status. Does the relationship exist in the elderly population?
    Bożentowicz-Wikarek M, Kocełak P, Owczarek A, Olszanecka-Glinianowicz M, Mossakowska M, Skalska A, Więcek A, Chudek J.
    Clin Biochem; 2015 Apr; 48(6):431-6. PubMed ID: 25583093
    [Abstract] [Full Text] [Related]

  • 3. Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men.
    Marsell R, Mirza MA, Mallmin H, Karlsson M, Mellström D, Orwoll E, Ohlsson C, Jonsson KB, Ljunggren O, Larsson TE.
    Osteoporos Int; 2009 Jul; 20(7):1167-73. PubMed ID: 18974917
    [Abstract] [Full Text] [Related]

  • 4. High Plasma Erythropoietin Predicts Incident Fractures in Elderly Men with Normal Renal Function: The MrOS Sweden Cohort.
    Kristjansdottir HL, Lewerin C, Lerner UH, Herlitz H, Johansson P, Johansson H, Karlsson M, Lorentzon M, Ohlsson C, Ljunggren Ö, Mellström D.
    J Bone Miner Res; 2020 Feb; 35(2):298-305. PubMed ID: 31626711
    [Abstract] [Full Text] [Related]

  • 5. Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men.
    Marsell R, Grundberg E, Krajisnik T, Mallmin H, Karlsson M, Mellström D, Orwoll E, Ohlsson C, Jonsson KB, Ljunggren O, Larsson TE.
    Eur J Endocrinol; 2008 Jan; 158(1):125-9. PubMed ID: 18166826
    [Abstract] [Full Text] [Related]

  • 6. Phosphate control in reducing FGF23 levels in hemodialysis patients.
    Rodelo-Haad C, Rodríguez-Ortiz ME, Martin-Malo A, Pendon-Ruiz de Mier MV, Agüera ML, Muñoz-Castañeda JR, Soriano S, Caravaca F, Alvarez-Lara MA, Felsenfeld A, Aljama P, Rodriguez M.
    PLoS One; 2018 Jan; 13(8):e0201537. PubMed ID: 30086150
    [Abstract] [Full Text] [Related]

  • 7. Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure.
    van Breda F, Emans ME, van der Putten K, Braam B, van Ittersum FJ, Kraaijenhagen RJ, de Borst MH, Vervloet M, Gaillard CA.
    PLoS One; 2015 Jan; 10(6):e0128994. PubMed ID: 26079688
    [Abstract] [Full Text] [Related]

  • 8. Fibroblast Growth Factor 23 (FGF23) and Klotho Protein in Beta-Thalassemia.
    Stefanopoulos D, Nasiri-Ansari N, Dontas I, Vryonidou A, Galanos A, Psaridi L, Fatouros IG, Mastorakos G, Papavassiliou AG, Kassi E, Tournis S.
    Horm Metab Res; 2020 Mar; 52(3):194-201. PubMed ID: 32215890
    [Abstract] [Full Text] [Related]

  • 9. Oral iron supplementation with sodium ferrous citrate reduces the serum intact and c-terminal fibroblast growth factor 23 levels of maintenance haemodialysis patients.
    Yamashita K, Mizuiri S, Nishizawa Y, Kenichiro S, Doi S, Masaki T.
    Nephrology (Carlton); 2017 Dec; 22(12):947-953. PubMed ID: 27558654
    [Abstract] [Full Text] [Related]

  • 10. Dysequilibrium of the PTH-FGF23-vitamin D axis in relapsing remitting multiple sclerosis; a longitudinal study.
    Stein MS, Ward GJ, Butzkueven H, Kilpatrick TJ, Harrison LC.
    Mol Med; 2018 May 30; 24(1):27. PubMed ID: 30134801
    [Abstract] [Full Text] [Related]

  • 11. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.
    Wolf M, Koch TA, Bregman DB.
    J Bone Miner Res; 2013 Aug 30; 28(8):1793-803. PubMed ID: 23505057
    [Abstract] [Full Text] [Related]

  • 12. Strength of Fibroblast Growth Factor 23 as a Cardiovascular Risk Predictor in Chronic Kidney Disease Weaken by ProBNP Adjustment.
    Emrich IE, Brandenburg V, Sellier AB, Schauerte J, Wiedenroth J, Untersteller K, Lennartz CS, Seiler-Mussler S, Wagenpfeil S, Fliser D, Heine GH.
    Am J Nephrol; 2019 Aug 30; 49(3):203-211. PubMed ID: 30808827
    [Abstract] [Full Text] [Related]

  • 13. Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study.
    Eisenga MF, De Jong MA, Van der Meer P, Leaf DE, Huls G, Nolte IM, Gaillard CAJM, Bakker SJL, De Borst MH.
    PLoS Med; 2019 Jun 30; 16(6):e1002818. PubMed ID: 31170159
    [Abstract] [Full Text] [Related]

  • 14. Serum estradiol associates with blood hemoglobin in elderly men: the MrOS Sweden study.
    Lewerin C, Nilsson-Ehle H, Jacobsson S, Johansson H, Sundh V, Karlsson MK, Lorentzon M, Barrett-Connor E, Vandenput L, Ohlsson C, Mellström D.
    J Clin Endocrinol Metab; 2014 Jul 30; 99(7):2549-56. PubMed ID: 24731011
    [Abstract] [Full Text] [Related]

  • 15. Serum fibroblast growth factor 23, serum iron and bone mineral density in premenopausal women.
    Imel EA, Liu Z, McQueen AK, Acton D, Acton A, Padgett LR, Peacock M, Econs MJ.
    Bone; 2016 May 30; 86():98-105. PubMed ID: 26965530
    [Abstract] [Full Text] [Related]

  • 16. Fibroblast growth factor 23 (FGF23) and early chronic kidney disease in the elderly.
    Chudek J, Kocełak P, Owczarek A, Bożentowicz-Wikarek M, Mossakowska M, Olszanecka-Glinianowicz M, Wiecek A.
    Nephrol Dial Transplant; 2014 Sep 30; 29(9):1757-63. PubMed ID: 24729016
    [Abstract] [Full Text] [Related]

  • 17. C-Terminal to Intact Fibroblast Growth Factor 23 Ratio in Relation to Estimated Glomerular Filtration Rate in Elderly Population.
    Bożentowicz-Wikarek M, Owczarek A, Kocełak P, Olszanecka-Glinianowicz M, Więcek A, Chudek J.
    Kidney Blood Press Res; 2016 Sep 30; 41(5):519-526. PubMed ID: 27529627
    [Abstract] [Full Text] [Related]

  • 18. Serum phosphate and phosphate-regulatory hormones in COPD patients.
    Stroda A, Brandenburg V, Daher A, Cornelissen C, Goettsch C, Keszei A, Dreher M.
    Respir Res; 2018 Sep 20; 19(1):183. PubMed ID: 30236113
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals.
    Mirza MA, Alsiö J, Hammarstedt A, Erben RG, Michaëlsson K, Tivesten A, Marsell R, Orwoll E, Karlsson MK, Ljunggren O, Mellström D, Lind L, Ohlsson C, Larsson TE.
    Arterioscler Thromb Vasc Biol; 2011 Jan 20; 31(1):219-27. PubMed ID: 20966399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.